Cart
sales@molnova.com
inS3-54-A26
CAS No. 328998-77-2
inS3-54-A26( —— )
Catalog No. M27885 CAS No. 328998-77-2
inS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 166 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameinS3-54-A26
-
NoteResearch use only, not for human use.
-
Brief DescriptioninS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
DescriptioninS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorERβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number328998-77-2
-
Formula Weight414.89
-
Molecular FormulaC25H19ClN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)Nc1ccc(cc1)N1C(=O)\C(=C/c2ccc(Cl)cc2)C=C1c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang X, et al. Total Synthesis of (+)-Medicarpin. J Nat Prod. 2017 Dec 22;80(12):3284-3288.
molnova catalog
related products
-
(-)-Catechin gallate
(-)-Catechin Gallate displays inhibition of 6PGD IDH. (-)-Catechin Gallate displays inhibition of human Beta-secretase.
-
[D-Ala4]-Substance P...
[DAla4] Substance P (4-11) is an analog of Substance P (Substance P ) that inhibits the binding of 125I-Bolton Hunter-conjugated Eledoisin (Eledoisin) (IC50 of 0.5 μM) and 125I-Bolton Hunter-conjugated Substance P (IC50 of 0.15 μM) to rat brain cortex membranes.
-
Magrolimab
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
